Mesalamine

Fenofibrate in Ulcerative Colitis

Pentoxifylline in Patients With Ulcerative Colitis

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

Desloratadine in Patients With Ulcerative Colitis

Rupatadine in Patients With Ulcerative Colitis

Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

Microbiota and Probiotic Therapy in Ulcerative Colitis Patients

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Nitazoxanide in Patients With Ulcerative Colitis

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis

Beneficial Effect of Silymarin in Ulcerative Colitis

Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)

Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations

Taste Assessment Study of SHP429 in Healthy Adult Subjects

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)